Youzhen Wang, PhD

Shanghai, China
Dr. Wang received her Bachelor's Degree from the Peking University Health Sciences Center and her Ph.D. in Biochemistry and Molecular Biology from the School of Medicine & Dentistry of New Jersey. She did her postdoctoral training at Children’s Hospital of Harvard Medical School. She then joined the pharmaceutical industry and has nearly 30 years’ experience in drug discovery and development, primarily in the oncology field. She served as a group leader, Senior Principal Investigator and Principal Scientist at Novartis, AstraZeneca and Millennium (now Takeda) Pharmaceuticals before joining CytosinLab Therapeutics. She participated in many projects at different stages of drug discovery and development, with seven drugs reaching FDA approval. She has extensive expertise in the areas of in vivo pharmacology, pre-clinical toxicology, precision and translational medicine.
Speaking In
3:30 PM - 5:00 PM (PDT)
Monday, June 13
Learn the latest about biomedical innovation within the China biotech community from this showcase…